ask="1.98"
ask_size="10000"
average_daily_volume="81084"
bid="0.90"
bid_size="1000"
book_value="0.95"
change="-0.03"
change_from_200_day_moving_average="-0.23"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-0.84"
change_From_52_week_low="0.23"
change_in_percent="-2.52%"
close="1.16"
dividend_pay_date="11/8/2012"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.75"
ebitda="-28.78M"
eps_estimate_current_year="-0.92"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-1.07"
ex_dividend_date="11/9/2012"
float_shares="30545000"
high="1.22"
high_52_weeks="2.00"
last_trade_date="2/3/2017"
last_trade_price="1.16"
last_trade_size="784"
last_trade_time="4:00pm"
low="1.12"
low_52_weeks="0.93"
market_capitalization="44.82M"
moving_average_200_day="1.39"
moving_average_50_day="1.28"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.17"
open="1.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-16.68%"
percent_change_from_50_day_moving_average="-9.18%"
percent_change_from_52_week_high="-42.00%"
percent_change_from_52_week_low="+24.73%"
previous_close="1.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.26"
price_per_sales="5.97"
revenue="7.70M"
shares_outstanding="38640000"
short_ratio="1.26"
stock_exchange="NMS"
symbol="AVIR"
volume="106470"
weeks_range_52="0.93 - 2.00"
